|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
Sutro Biopharma Lands $16,500,000 Series C Funding
|
VentureDeal |
05/08/12 |
San Francisco
|
|
SD Life Sciences Roundup: Illumina, Sophiris Bio, & New Funding Deals
|
Bruce V. Bigelow |
04/05/12 |
San Diego
|
|
San Diego Life Sciences Roundup: Isis, Elevation, Proacta, and More
|
Bruce V. Bigelow |
01/06/12 |
San Diego
|
|
Pfizer Acquires Excaliard, an Isis Spinout With Drug to Fight Excessive Scarring
|
Luke Timmerman |
11/22/11 |
San Diego
|
|
Portola Grabs $45M Upfront From Biogen Idec to Develop Autoimmune Drugs
|
Luke Timmerman |
10/27/11 |
San Francisco
|
|
Raising Funds: AnaptysBio, Sonexa, Eclipse, NextDx, Naviscan
|
Bruce V. Bigelow |
10/18/11 |
San Diego
|
|
Light Sciences Stumbles, Cardiac Dimensions Gets EU OK, Immune Design Pockets $11M, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
10/06/11 |
Seattle
|
|
Immune Design Rakes In Another $11M From Prior VC Round
|
Luke Timmerman |
10/05/11 |
Seattle
|
|
SARCode Secures $44,000,000 Series B Round
|
VentureDeal |
07/18/11 |
San Francisco
|
|
With Esperion Reboot, Lipitor Co-Discoverer Roger Newton Pushes For Therapy Beyond Drugs
|
Thomas Lee |
05/25/11 |
Detroit
|
|
Gilead Buys Calistoga Pharma for $375M, Making Move Into Cancer Drugs
|
Luke Timmerman |
02/22/11 |
Seattle
|
|
Vertiflex Lands $14,000,000 Series D Financing Round
|
VentureDeal |
02/02/11 |
San Diego
|
|
Alexion Pharma Gobbles Up Taligen in $111M Buyout
|
Ryan McBride |
01/31/11 |
Boston
|
|
AcelRx Prices IPO
|
Wade Roush |
01/21/11 |
San Francisco
|
|
PneumRx Raises $33M
|
Wade Roush |
01/04/11 |
San Francisco
|
|
Sutro Biopharma Grabs $36.5M in Venture Deal to Make “Biobetters”
|
Luke Timmerman |
11/17/10 |
San Francisco
|
|
Sutro Biopharma Secures $36,500,000 Series C Round
|
VentureDeal |
11/17/10 |
San Francisco
|
|
Ceregene Adds $11.5M
|
Luke Timmerman |
11/11/10 |
San Diego
|
|
Ceregene Lands $11,500,000 Series D Round
|
VentureDeal |
11/11/10 |
San Diego
|
|
ChemoCentryx, Pursuing the Dream For Autoimmune Disease, Seeks to Put a Pill in a Bottle
|
Luke Timmerman |
11/04/10 |
San Francisco
|
|
Life Technologies’ CEO Talks Strategy, Phenomix Falls, Arena Pharmaceuticals Grapples With FDA Setback, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
10/28/10 |
San Diego
|
|
ATyr Pharma Pockets $23M to Create New Class of Protein Drugs, and New Targets
|
Luke Timmerman |
10/26/10 |
San Diego
|
|
Phenomix, Former Highflying Diabetes Drugmaker, Shuts Down After Forest Labs Walks
|
Luke Timmerman |
10/26/10 |
San Diego
|
|
aTyr Pharma Obtains $23,000,000 Series C Financing
|
VentureDeal |
10/26/10 |
San Diego
|
|
Cerenis Adds $13.9M to C Round
|
Ryan McBride |
10/21/10 |
Detroit
|
|
Pathwork Diagnostics Lands $30,000,000 Series C Financing Round
|
VentureDeal |
10/06/10 |
San Francisco
|
|
VMware Makes Two Acquisitions, Mascoma Picks Up SunOpta Unit, Vela Gets $6M, & More Boston-Area Deals News
|
Erin Kutz |
09/08/10 |
Boston
|
|
Pfizer Gobbles FoldRx in Big Pharma’s Latest Rare Disease Play in Boston Area
|
Ryan McBride |
09/01/10 |
Boston
|
|
Promising Skin Cancer Drug Could Be First Big Win for Plexxikon’s Structure-Based Drug Discovery Approach
|
Wade Roush |
08/26/10 |
San Francisco
|
|
Anchor Sinks $10M Series B, Aileron Lands Deal with Roche, C Change Launches Fund With Vanterra, & More Boston-Area Deals News
|
Erin Kutz |
08/25/10 |
Boston
|
|
Page 1 of
3 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.